PIL - Accofil® 12 MU/0.2 ml solution for injection or infusion in pre-filled syringe: Change history
View Patient Information Leaflet (PIL - Accofil® 12 MU/0.2 ml solution for injection or infusion in pre-filled syringe)
Last updated on this site: 26 Jun 2025
Description of update: To update sections 2, 4.2, 4.4, 4.5, 4.8, 4.9, 5.1 and 5.2 and the PIL in line with the reference product Neupogen, Singleject 30 MU (0.6 mg/mL) & 48 MU (0.96 mg/mL) solution for injection in a pre-filled syringe (PL 16216/0043-0044, MAH: Amgen Europe B.V).
PIL sections updated: Product title, 6.
Last updated on this site: 26 Jun 2025
Description of update: To update sections 2, 4.2, 4.4, 4.5, 4.8, 4.9, 5.1 and 5.2 and the PIL in line with the reference product Neupogen, Singleject 30 MU (0.6 mg/mL) & 48 MU (0.96 mg/mL) solution for injection in a pre-filled syringe (PL 16216/0043-0044, MAH: Amgen Europe B.V).
PIL sections updated: Product title, 6.
-
Changes: (Updated: 26 Jun 2025)
Description of update: To update sections 2, 4.2, 4.4, 4.5, 4.8, 4.9, 5.1 and 5.2 and the PIL in line with the reference product Neupogen, Singleject 30 MU (0.6 mg/mL) & 48 MU (0.96 mg/mL) solution for injection in a pre-filled syringe (PL 16216/0043-0044, MAH: Amgen Europe B.V).
PIL sections updated: Product title, 6.
-
Changes: (Updated: 02 Aug 2023)
To update sections 2, 3, 4.2, 4.4, 4.6, 4.8, 5.1, 5.2, 5.3, 6.2, 6.6 of the SmPC and PIL, in line with the reference product information Neupogen, Singleject 30 MU (0.6 mg/mL) & 48 MU (0.96 mg/mL) solution for injection in a pre-filled syringe) by MAH Amgen Europe B.V. PL 16216/0043.
-
Changes: (Updated: 21 Oct 2022)
Update
-
Changes: (Updated: 21 Sep 2022)
Initial upload